Delivery Order SPE2DB22D3501-SPE2DB23FWL51
Award Date 7/18/23
Potential Completion Date 7/19/23
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,878.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561756377 units of 84 mg doses of SPRAVATO. SPRAVATO is an esketamine nasal spray indicated for treatment-resistant depression. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle and has a period of performance from August 9-10, 2023. No...
- The Defense Logistics Agency awarded a $27,734 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561450730 units of 84 mg doses of SPRAVATO. SPRAVATO is an esketamine nasal spray indicated for treatment-resistant depression. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the doses to a location in Conshohocken, Pennsylvania by July 11, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $7,132 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 84 mg doses of SPRAVATO (esketamine) nasal spray. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 21-22, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...
- The Defense Logistics Agency awarded a $5,616.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack UDS (unit dose packs) with a completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a specialized nasal spray medication indicated for treatment-resistant depression, representing a critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,852.37 to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack unit dose systems (UDS), with completion scheduled for November 14, 2025. This firm fixed price delivery order, awarded on November 13, 2025, represents a non-set-aside competitive award and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. SPRAVATO is a nasal spray formulation of esketamine indicated for...
- The Defense Logistics Agency awarded a $7,489.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 84 mg doses of SPRAVATO, to be delivered to a location in Conshohocken, Pennsylvania by October 25, 2023. SPRAVATO is a brand name drug used to treat treatment-resistant depression, and this contract provides doses of that drug to support the Defense Logistics Agency's medical supply program. No set-aside provision was specified for this award. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- The Defense Logistics Agency awarded a $6,361 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562252303, described as 84 mg dose packs of Spravato. Spravato is an esketamine nasal spray used to treat treatment-resistant depression and suicidal thoughts. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 20-21, 2023. No set aside designation or subcontractors are identified. The Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,688 to Amerisourcebergen Drug Corporation to supply 4561933884 units of 56 mg doses of Spravato. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania by August 25, 2023 under the contract start and end dates. The Defense Logistics Agency is the funding agency for this requirement to support its medical supply chain initiatives. No...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,370.46 to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack UDS (unit dose system). This firm fixed-price delivery order, awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract place of performance is AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWL51Delivery Order
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $10,162.71 firm fixed price delivery order contract to provide 4561535214 doses of 84 mg SPRAVATO dose packs. SPRAVATO is an esketamine nasal spray used to treat treatment-resistant depression and post-traumatic stress disorder. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day contract period is July 18 through July 19, 2023, indicating an urgent need to replenish DLA's pharmaceutical inventory in support of the Department of Defense's mental health programs. No subcontractors or set aside designations were identified.
Generated 12/24/23, 4:33 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 7/18/23 |